Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain-containing protein 46 (ANKRD46) is a cellular protein characterized by multiple ankyrin repeat motifs, which mediate protein-protein interactions involved in diverse cellular processes. ANKRD46 is regulated by microRNAs (e.g., miR-21 and miR-451) that affect its expression and, consequently, impact cell proliferation, migration, embryo implantation, and tissue development. Emerging research implicates altered ANKRD46 expression in certain cancers (such as breast and thyroid), as well as in tissue quality traits in animals. Although ANKRD46 has important regulatory roles, it is not currently considered a direct therapeutic target such as a receptor or enzyme[1][2][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain-containing protein 46 (ANKRD46).